Cancer nanotechnology: The impact of passive and active targeting in the era of modern cancer biology
Massachusetts Institute of Technology · Brigham and Women's Hospital · +2 more institutions
Indexed incrossrefpubmed
Abstract
No abstract available for this paper.
Citation impact
2,747
total citations
- FWCI
- 93.04
- Percentile
- 100%
- References
- 342
Citations per year
Authors
5- NBNicolas Bertrand
Massachusetts Institute of Technology
- JWJun Wu
Brigham and Women's Hospital, Harvard University
- XXXiaoyang Xu
Brigham and Women's Hospital, Harvard University, Innovation Research Center, Massachusetts Institute of Technology
- NKNazila Kamaly
Brigham and Women's Hospital, Harvard University
- OCOmid C. FarokhzadCorresponding
Brigham and Women's Hospital, Harvard University, Innovation Research Center
Topics & keywords
Topics
Keywords
- Commercialization
- Nanomedicine
- Medicine
- Nanotechnology
- Tolerability
- Cancer
- Drug development
- Personalized medicine
UN Sustainable Development Goals
- Partnerships for the goals
No related works found for this paper.